Summerset, New Zealand’s third largest care provider, underwent a 6-month pilot project where they introduced and trialled PainChek®, the world’s first regulatory-cleared medical device for the assessment of pain, at their Levin Care Centre.
Following a successful pilot period, PainChek® will now be present at all 24 of Summerset’s care centres in New Zealand, with the roll-out expected to take place throughout 2022.
During the initial 6-month pilot project, and in the months that followed, PainChek® was able to provide a positive change to the response rate of care centre staff when attending to residents who may be in pain but unable to reliably self-report.
Of the results achieved, Linda Irvine, Head of Clinical Services at Summerset, believes the greatest benefit of PainChek® was that it enabled care staff to accurately assess and manage pain for all residents –
“PainChek really made us think about how important effective pain management is for older people and a key advantage is being able to rule out pain as a contributing factor for residents who are at times distressed.”
David Allsopp, Head of Business Development ANZ at PainChek, said,
“PainChek is very excited to be partnering with one of New Zealand’s premier Care Providers. Summerset has a long history of innovation in care, with this innovation supporting their rapid growth to become the third largest Provider in the country. PainChek’s pilot conducted at Summerset’s Levin Care Centre demonstrated how quickly and effectively PainChek can be implemented remotely, even internationally, and we look forward to completing our implementation across all Summerset Care Centres, and with other Care Providers across New Zealand.”
The roll-out will see PainChek® present in 1,150 beds across Summerset’s 24 care centres.
Summerset now joins more than 1,500 facilities around the world who have implemented PainChek® to enable best-practice pain assessment and management.
For more information on Summerset, visit: www.summerset.co.nz
